Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 150 Results

Title
Intervention Indication Therapeutic Area Year Actions
Tanezumab for cancer pain due to bone metastasis Tanezumab (PF-04383119; RN624) Cancer pain Bone and Cartilage Cancer , Oncology 2020 View  |  Download
Tecarfarin for preventing venous thromboembolism Tecarfarin (ATI-5923) Thromboembolism Cardiovascular System , Haematology 2020 View  |  Download
Tepotinib for advanced non-small cell lung cancer harbouring MET exon14- skipping mutations Tepotinib (MSC-2156119J; TEPMETKO) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2020 View  |  Download
Tezepelumab for severe, uncontrolled asthma Tezepelumab (AMG 157; MEDI9929) Asthma Respiratory System 2020 View  |  Download
Tideglusib for congenital myotonic dystrophy Tideglusib (AMO-02; Zentylor; Nypta; NP031112) Myotonic dystrophy Genetic Disorders , Musculoskeletal System , Neurology 2020 View  |  Download
Timrepigene emparvovec for choroideremia Timrepigene emparvovec (BIIB111; AAV2-REP1; NSR-REP1) Choroideremia Ophthalmology 2020 View  |  Download
Tofacitinib for Ankylosing Spondylitis Tofacitinib citrate (Xeljanz; CP-690550) Ankylosing spondylitis Musculoskeletal System 2020 View  |  Download
Tofersen for the treatment of amyotrophic lateral sclerosis caused by mutations in the SOD1 gene Tofersen sodium (BIIB067) Motor neurone disease (MND or ALS) Neurology 2020 View  |  Download
Tralesinidase alfa for mucopolysaccharidosis type IIIB (Sanfilippo syndrome type B) Tralesinidase alfa (BMN 250) Mucopolysaccharidosis type IIIB (Sanfilippo B syndrome) Endocrine Nutritional and Metabolic Disorders 2020 View  |  Download
Tralokinumab for adolescents with moderate to severe atopic dermatitis Tralokinumab (CAT-354; LP 0162) Atopic dermatitis Dermatology 2020 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications